Evidence map›Paper›PMID 32067294›Full record

ArticleAngewandte Chemie (International ed. in English)2020

Total Synthesis of a Mycolic Acid from Mycobacterium tuberculosis.

Nabil Tahiri, Peter Fodran, Dhineshkumar Jayaraman, Jeffrey Buter, Martin D Witte, Tonatiuh A Ocampo, D Branch Moody, Ildiko Van Rhijn, Adriaan J Minnaard

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Asymmetric Total Synthesis and Structural Revision of DATAngewandte Chemie (International ed. in English) · 2024
    Article
  4. Effect of Mycolic Acids on Host Immunity and Lipid Metabolism.International journal of molecular sciences · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Total Synthesis of a Mycolic Acid from Mycobacterium tuberculosis.Angewandte Chemie (International ed. in English) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Nabil TahiriStratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands.
Peter FodranStratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands.ORCID 0000-0003-0348-8331
Dhineshkumar JayaramanStratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands.
Jeffrey ButerStratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands.ORCID 0000-0002-4440-6702
Martin D WitteStratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands.ORCID 0000-0003-4660-2974
Tonatiuh A OcampoBrigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Harvard Medical School, Hale BTM, 60 Fenwood Road, Boston, MA, 02115, USA.
D Branch MoodyBrigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Harvard Medical School, Hale BTM, 60 Fenwood Road, Boston, MA, 02115, USA.
Ildiko Van RhijnBrigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity, Harvard Medical School, Hale BTM, 60 Fenwood Road, Boston, MA, 02115, USA.ORCID 0000-0002-1446-5701
Adriaan J MinnaardStratingh Institute for Chemistry, University of Groningen, Nijenborgh 7, 9747 AG, Groningen, The Netherlands.ORCID 0000-0002-5966-1300
University of Groningen · NLBrigham and Women's Hospital · US

Funding

Metabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MURRAY, MEGAN, MURRAY, MEGAN B · 2015 to 2021
$20.4M
T cell response to CDI-restricted lipids in tuberculosisR01AI049313 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2001 to 2025
$10.6M
NIAID NIH HHS R01 AI049313NIAID NIH HHS U19 AI111224
6 · The paper itself

Abstract

In Mycobacterium tuberculosis, mycolic acids and their glycerol, glucose, and trehalose esters ("cord factor") form the main part of the mycomembrane. Despite their first isolation almost a century ago, full stereochemical evaluation is lacking, as is a scalable synthesis required for accurate immunological, including vaccination, studies. Herein, we report an efficient, convergent, gram-scale synthesis of four stereo-isomers of a mycolic acid and its glucose ester. Binding to the antigen presenting protein CD1b and T cell activation studies are used to confirm the antigenicity of the synthetic material. The absolute stereochemistry of the syn-methoxy methyl moiety in natural material is evaluated by comparing its optical rotation with that of synthetic material.

Indexed as

Antigens, CD1Cell MembraneEstersGlucoseLymphocyte ActivationMycobacterium tuberculosisMycolic AcidsStereoisomerismT-LymphocytesTumor Necrosis Factor Receptor Superfamily, Member 7Antigens, CD1CD1b antigenEstersGlucoseMycolic AcidsTumor Necrosis Factor Receptor Superfamily, Member 7CD1bcross couplingmycolic acidtotal synthesistuberculosis

Identifiers

PMID32067294
PMCPMC7216993
OpenAlexW3007217767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.